PharmaForceIQ has acquired Aktana, a leader in intelligent customer engagement for the global life sciences industry, for an undisclosed amount. This acquisition marks a significant expansion for PharmaForceIQ, integrating Aktana's advanced AI-driven platform into its portfolio. Aktana is renowned for helping life science companies strengthen their relationships with healthcare providers by tailoring customer experiences to individual preferences and needs, ultimately inspiring better patient care.
Aktana's core offering is its AI-enabled Contextual Intelligence Engine, which enables commercial and medical teams to coordinate and optimize personalized omnichannel engagement at scale. The company boasts an impressive client roster, serving more than 350 brands, including over half of the world’s top 20 pharmaceutical companies. Headquartered in San Francisco, Aktana maintains a global presence with offices in major biopharma regions worldwide. This established market leadership and technological sophistication are key assets in the acquisition.
The strategic rationale behind this acquisition centers on enhancing PharmaForceIQ's capabilities within the life sciences technology sector. By integrating Aktana's proven intelligent engagement platform, PharmaForceIQ aims to offer a more comprehensive suite of solutions, enabling clients to achieve more effective and personalized interactions with healthcare professionals. The synergy is expected to drive innovation in data-driven customer engagement, combining Aktana's AI expertise with PharmaForceIQ's strategic vision to deliver superior value to the pharmaceutical and life sciences industries.
This combination is poised to create a more robust entity capable of addressing the evolving demands for sophisticated, personalized engagement strategies in a highly competitive market. The integration of Aktana's technology and customer base is anticipated to accelerate the development of next-generation tools that empower life science companies to optimize their commercial and medical outreach, fostering stronger relationships and improving patient outcomes globally.